Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphoseek and ICG for SLN Detection in Endometrial Cancer
NCT04511026Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of technetium tc 99m tilmanocept in endometrial cancer (EC), sponsored by Stanford University. Started Jan 2021; status: terminated.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT04511026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04511026.